Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Pricing and availability of generic Indian Ledipasvir and Sofosbuvir co-formulation as on 26 April 2016
Pricing and availability of generic Indian Ledipasvir and Sofosbuvir co-formulation as on 26 April 2016
Download PDF
May 3, 2016
/
News
Share
the Post
Related
Posts
Support letter for inclusion of Daclatasvir on 4th March, 2015.
IAC a community group in Indonesia demanding national food and drugs authority to expedite registration process of DAA medicines in Indonesia
Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C
18 hospitals offer free DAA therapy for treatment of Hepatitis C in Malaysia
Asia Pacific Situational Updates on Generic DAAs – June 2017
Read More
Story from Ajitshwor Wangkheirakpam, Manipur, India
New WHO guideline on care and treatment of chronic hepatitis C
Pricing of Indian generic sofosbuvir, 30th Jan,2016
